Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myobloc vs Botox for Muscle Atrophy in Spasticity
NCT02052024Phase 4Completed
- Sponsor
- Georgetown University
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type b in spasticity (2 arms), sponsored by Georgetown University. Primary endpoint: Volume and Cross-Sectional Area of Muscle at 36 weeks. Started May 2014; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT02052024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052024.